Revenue for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's current revenue (TTM) is $48.19B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$48.19B
YoY change
-0.2%
5Y CAGR
+2.5%
Peak year (2024)
$48.30B
Cumulative revenue
$829.91B
Revenue history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Revenue history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $48.19B | -0.2% | ||
| 2024 | $48.30B | +7.3% | ||
| 2023 | $45.01B | -2.5% | ||
| 2022 | $46.16B | -0.5% | ||
| 2021 | $46.38B | +9.1% | ||
| 2020 | $42.52B | +62.6% | ||
| 2019 | $26.14B | +15.9% | ||
| 2018 | $22.56B | +8.6% | ||
| 2017 | $20.78B | +6.9% | ||
| 2016 | $19.43B | +17.3% | ||
| 2015 | $16.56B | +4.3% | ||
| 2014 | $15.88B | -3.1% | ||
| 2013 | $16.39B | -7.0% | ||
| 2012 | $17.62B | -17.1% | ||
| 2011 | $21.24B | +9.0% | ||
| 2010 | $19.48B | +3.6% | ||
| 2009 | $18.81B | -8.7% | ||
| 2008 | $20.60B | +6.5% | ||
| 2007 | $19.35B | +8.0% | ||
| 2006 | $17.91B | -6.7% | ||
| 2005 | $19.21B | -0.9% | ||
| 2004 | $19.38B | -7.2% | ||
| 2003 | $20.89B | +15.3% | ||
| 2002 | $18.12B | -6.7% | ||
| 2001 | $19.42B | +6.6% | ||
| 2000 | $18.22B | -9.9% | ||
| 1999 | $20.22B | +10.6% | ||
| 1998 | $18.28B | +9.5% | ||
| 1997 | $16.70B | +10.9% | ||
| 1996 | $15.06B | +9.4% | ||
| 1995 | $13.77B | +14.9% | ||
| 1994 | $11.98B | +5.0% | ||
| 1993 | $11.41B | +2.3% | ||
| 1992 | $11.16B | -0.0% | ||
| 1991 | $11.16B | +8.3% | ||
| 1990 | $10.30B | +12.1% | ||
| 1989 | $9.19B | +7.4% | ||
| 1988 | $8.56B | +13.2% | ||
| 1987 | $7.56B | — |
Revenue values are taken from Bristol-Myers Squibb's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Bristol-Myers Squibb (BMY) reported revenue of $48.19B – edged down 0.2% year-over-year.
Through 2020–2025 (5 years), Bristol-Myers Squibb revenue delivered a +2.5% annualised rate; with the latest reading among the more recent periods of the dataset.
The highest annual revenue of $48.30B was reported in 2024. The lowest in the available history was $7.56B in 1987.
Within Healthcare, Bristol-Myers Squibb (BMY) ranks 8th among 8 peers we track. The peer median for revenue is $65.09B.
Bristol-Myers Squibb Revenue by Year
Bristol-Myers Squibb Revenue 2025: $48.19B
Bristol-Myers Squibb revenue in 2025 was $48.19B, edged down 0.2% below 2024.
Bristol-Myers Squibb Revenue 2024: $48.30B
Bristol-Myers Squibb revenue in 2024 was $48.30B, grew 7.3% from 2023. This figure represents the highest annual value in the available history.
Bristol-Myers Squibb Revenue 2023: $45.01B
Bristol-Myers Squibb revenue in 2023 was $45.01B, edged down 2.5% below 2022.
Bristol-Myers Squibb Revenue 2022: $46.16B
Bristol-Myers Squibb revenue in 2022 was $46.16B, edged down 0.5% below 2021.
Bristol-Myers Squibb Revenue 2021: $46.38B
Bristol-Myers Squibb revenue in 2021 was $46.38B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Revenue
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's revenue?
- Latest reported revenue for Bristol-Myers Squibb (BMY) is $48.19B (period ending December 31, 2025).
How has Bristol-Myers Squibb revenue changed year-over-year?
- Bristol-Myers Squibb (BMY) revenue changed -0.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb revenue?
- Bristol-Myers Squibb (BMY) revenue compound annual growth rate is +2.5% over the most recent 5 years available.
When did Bristol-Myers Squibb revenue hit its highest annual value?
- Bristol-Myers Squibb revenue reached its highest annual value of $48.30B in 2024.
What was Bristol-Myers Squibb revenue in 2024?
- Bristol-Myers Squibb (BMY) revenue in 2024 was $48.30B.
What was Bristol-Myers Squibb revenue in 2025?
- Bristol-Myers Squibb (BMY) revenue in 2025 was $48.19B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.